Search clinical trials for: pembrolizumab and lenvatinib
Total 272855 results
-
Eisai Inc.Completed
-
3D Medicines (Sichuan) Co., Ltd.RecruitingAdvanced Endometrial CancerChina
-
Fudan UniversityRecruitingIntrahepatic CholangiocarcinomaChina
-
Eisai Co., Ltd.Completed
-
Sun Yat-sen UniversityUnknownHepatocellular CarcinomaChina
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingHepatocellular Carcinoma Stage III
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnPancreatic Ductal Adenocarcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Homologous Recombination Deficiency | Stage IIA Pancreatic Cancer AJCC v8 | Stage IIB Pancreatic Cancer AJCC v8 | ATM Gene Mutation | Deleterious BRCA1 Gene... and other conditions
-
RenJi HospitalCompletedLenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular CarcinomaHepatocellular Carcinoma | Molecular Targeted TherapyChina
-
Aaron WolfsonRecruitingRecurrent Endometrial Carcinoma | Unresectable Endometrial CarcinomaUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCRecruitingNeuroendocrine Tumors | High Grade Neuroendocrine Carcinoma, Any Site | Well-Differentiated Neuroendocrine CarcinomaUnited States
-
AkesoNot yet recruiting
-
Zhejiang Cancer HospitalRecruitingHepatocellular Carcinoma | Oxaliplatin | TACE | Lenvatinib | Tislelizumab | PharmorubicinChina
-
Henan Cancer HospitalRecruiting
-
Fudan UniversityRecruitingPancreatic Ductal AdenocarcinomaChina
-
Chang Gung Memorial HospitalMinistry of Health and Welfare, TaiwanRecruitingHigh Risk of RecurrenceTaiwan
-
Sun Yat-sen UniversityNot yet recruitingPotentially Resectable Hepatocellular Carcinoma
-
Shanghai Junshi Bioscience Co., Ltd.TerminatedHepatocellular CarcinomaChina
-
Shanghai Zhongshan HospitalUnknownCholangiocarcinoma, IntrahepaticChina
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Stage IV Non-Small Cell Lung CancerUnited States
-
Hadassah Medical OrganizationRecruiting
-
Shanghai Zhongshan HospitalActive, not recruitingBiliary Tract Cancer | PD-1 Antibody | Lenvatinib | GemoxChina
-
Eisai Inc.CompletedThyroid CancerUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Denmark, France, Germany, Italy, Japan, Korea, Republic of, Poland, Portugal, Romania, Russian Federation, Spain, Sweden, Thailand, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingStage III Thymoma AJCC v8 | Stage IIIA Thymoma AJCC v8 | Stage IIIB Thymoma AJCC v8 | Stage IV Thymoma AJCC v8 | Stage IVA Thymoma AJCC v8 | Stage IVB Thymoma AJCC v8 | Unresectable Thymic CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast Cancer AJCC v8 | Prognostic Stage IIIC Breast Cancer AJCC v8 | Breast Inflammatory CarcinomaUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingHead and Neck Squamous Cell CarcinomaUnited States, Australia, Brazil, Canada, China, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
National Cancer Institute (NCI)SuspendedEndometrial Cancer | Endometrial Carcinoma | Cancer of Endometrium | Carcinoma of EndometriumUnited States
-
Cancer Hospital of Guangxi Medical UniversityActive, not recruitingTACE | Lenvatinib | Tislelizumab | Advanced Unresectable Hepatocellular CarcinomaChina
-
Northwestern UniversityNational Cancer Institute (NCI)TerminatedPancreatic Adenocarcinoma | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8United States
-
Shanghai Zhongshan HospitalWest China Hospital; Tongji Hospital; Anhui Provincial HospitalUnknownHepatocellular Carcinoma (HCC)China
-
IFOM ETS - The AIRC Institute of Molecular OncologyActive, not recruitingColorectal Neoplasms | Microsatellite InstabilityItaly
-
Peking UniversityRecruitingHepatocellular Carcinoma | Portal Vein ThrombosisChina
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMycosis Fungoides | Sezary Syndrome | Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 | Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8 | Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8 | Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8 | Stage III Mycosis Fungoides... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingBladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Invasive Bladder Mixed CarcinomaUnited States, Guam, Puerto Rico
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingGlioblastoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Advanced Solid Tumors | Triple Negative Breast Cancer | Biliary Tract CancersUnited States, Argentina, Australia, Canada, Chile, Colombia, France, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
Sun Yat-sen UniversityRecruitingHepatocellular CarcinomaChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRenal Cell CarcinomaPoland, Australia, United States, Canada, France, Hungary, Ireland, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
Tianjin Medical University Cancer Institute and...RecruitingPotentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder CancerChina
-
Peking Union Medical College HospitalShanghai Junshi Bioscience Co., Ltd.RecruitingAdvanced Biliary Tract CancerChina
-
Sun Yat-sen UniversityRecruiting
-
Peking Union Medical College HospitalShanghai Junshi Bioscience Co., Ltd.Recruiting
-
Xinrui ZhuEnrolling by invitationHepatocellular Carcinoma Non-resectable | Tyrosine Kinase Inhibitor | Transarterial Chemoembolization | Immune Checkpoint BlockadeChina
-
Alfred Chung, MDMerck Sharp & Dohme LLCTerminatedMultiple Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Zhejiang UniversityNot yet recruitingHepatocellular CarcinomaChina
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingHepatocellular Carcinoma Non-resectableChina
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced Non-Small Cell Lung CancerPoland, Russian Federation, United States, Australia, Canada, Hong Kong, Ireland, Italy, Japan, Korea, Republic of, Singapore, South Africa, Spain, Switzerland, Taiwan, United Kingdom
-
Jinling Hospital, ChinaRecruitingNeoplasms | Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms | Kidney Diseases | Urologic Diseases | Carcinoma | Antineoplastic Agents | Male Urogenital Diseases | Female Urogenital Diseases | Immune Checkpoint Inhibitors | Urogenital DiseasesChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnEsophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction AdenocarcinomaUnited States
-
Guangxi Medical UniversityCompleted
-
Peking Union Medical College HospitalRecruitingBiliary Tract Neoplasms | ImmunotherapyChina
-
Floor Backes, MDActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian CarcinomaUnited States